Prophylactic Administration of Perampanel for Post-Stroke Epilepsy(PROPELLER study)

未提供0 个研究点目标入组 54 人开始时间: 2023年10月20日最近更新: 2024年10月8日

适应症

试验速览

暂无简介。

•Patients with subcortical hemorrhage available for registration within 1 week
•Patients'age at onset between 50 and 90 years
•Patients capable of oral intake,including tube feeding
•Patients who have been fully informed of the details of this clinical research and who have given their written consent,either by the research subject or by a surrogate

•Patients with a history of epilepsy
•Patients taking antiepileptic drugs
•Patients whose cerebral hemorrhage is known to be caused by a vascular malformation such as arteriovenous malformation or moyamoya disease, or is traumatic in nature
•Patients with severe renal or hepatic impairment
•Patients with pregnant or breast feeding
•Patients with allergy to the target drug
•Patients who are judged to be inappropriate as research subjects by the principal investigator (subinvestigator)

Percentage of epilepsy incidence in the first 3 years after initiation of protocol treatment.

发起方

未提供